Adicet Bio Inc ACET 深沪

已收盘 02-06 16:00:00 美东时间

7.03

+0.590

+9.16%

华盛通

立即下载

最高7.03
今开6.55
成交量 22.63万股
最低 6.55
昨收 6.44
总市值 6733.67万
52周最高 17.4384
市盈率 ^静 --
换手率 2.36%
52周最低 6.4066
委比 87.50%
总股本 957.85万
历史最高 3606.40
量比 1.39
振幅 7.45%
历史最低 6.4066
每手 1
风险率 2.28%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

Adicet Bio CEO to Present at Guggenheim Emerging Outlook Biotech Summit

Adicet Bio CEO to Present at Guggenheim Emerging Outlook Biotech Summit Adicet Bio, Inc., a clinical stage biotechnology company focused on developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, will participate in the Guggenheim Emerging Outlook: Biotech Summit 2026.

01-30 20:00
美股大行评级 | 奈飞绩后遭13家大行下调目标价；齐昂银行、美国合众银行获多家机构上调目标价

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从9美元升至50美元；韦德布什：维持Ardelyx, Inc."跑赢大市"评级，目标价从16美元升至19美元

01-22 15:09
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $50

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $9 to $50.

01-21 19:33
Adicet Bio Extends Cash To 2027 As Enrollment Doubles For Lead Autoimmune Drug

Adicet Bio, Inc. (NASDAQ:ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer, today provided corporate updates and

01-07 20:14
Johnson & Johnson Touts Encouraging Results For Experimental Lupus Treatment

Johnson & Johnson reported encouraging Phase 2 results for its experimental lupus drug nipocalimab in patients with SLE.

01-07 02:42
What's Going On With Adicet Bio Stock Today?

Shares of Adicet Bio are trading lower after the clinical stage biotechnology company announced a one-for-16 reverse stock split.

2025-12-27 00:21
Adicet Bio shares are trading lower after the company announced a 1-for-16 reverse stock split.

Adicet Bio shares are trading lower after the company announced a 1-for-16 reve...

2025-12-26 21:31
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元

2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级

今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元

2025-11-10 10:22
HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $9

HC Wainwright & Co. analyst Robert Burns maintains Adicet Bio (NASDAQ:ACET) with a Buy and raises the price target from $4 to $9.

2025-11-07 20:38

派息除权日	每股总股息	派息日期
2018-09-21	0.010	2018-10-09
2018-06-07	0.010	2018-06-22
2018-03-08	0.06	2018-03-23
2017-12-15	0.06	2017-12-28
2017-09-07	0.06	2017-09-21
2017-06-07	0.06	2017-06-23
2017-03-08	0.06	2017-03-24
2016-12-08	0.06	2016-12-22
2016-09-07	0.06	2016-09-20
2016-06-07	0.06	2016-06-24
2016-03-09	0.06	2016-03-25
2015-12-15	0.06	2015-12-28
2015-09-17	0.06	2015-10-02
2015-06-09	0.06	2015-06-25
2015-03-10	0.06	2015-03-26
2014-12-11	0.06	2014-12-29
2014-09-11	0.06	2014-09-29
2014-06-10	0.06	2014-06-27
2014-03-11	0.06	2014-03-28
2013-12-12	0.06	2013-12-27
2013-09-12	0.06	2013-09-27
2013-06-12	0.05	2013-06-25
2013-03-13	0.05	2013-03-26
2012-12-13	0.05	2012-12-28
2012-09-13	0.05	2012-09-28
2012-06-07	0.10	2012-06-22
2011-12-23	0.10	2012-01-18
2011-06-09	0.10	2011-06-24
2010-12-22	0.10	2011-01-21
2010-06-10	0.10	2010-06-25
2009-12-22	0.10	2010-01-15
2009-06-11	0.10	2009-06-26
2008-12-17	0.10	2009-01-13
2008-06-12	0.10	2008-06-27
2008-02-20	0.05	2008-03-07
2007-12-19	0.10	2008-01-11
2007-06-14	0.10	2007-06-28
2006-12-20	0.08	2007-01-12
2006-06-15	0.08	2006-06-29
2005-12-21	0.08	2006-01-11
2005-06-16	0.08	2005-06-30
2004-12-21	0.11	2005-01-10
2004-06-10	0.09	2004-06-25
2003-12-15	0.13	2004-01-02
2003-06-12	0.12	2003-06-27
2002-12-16	0.17	2003-01-02
2002-06-13	0.16	2002-06-28
2001-12-17	0.16	2002-01-02
2001-06-14	0.16	2001-06-29
2000-12-15	0.15	2001-01-02
2000-06-15	0.15	2000-06-29
1999-12-16	0.15	2000-01-03
1999-06-11	0.13	1999-06-29
1998-12-17	0.13	1999-01-04
1998-06-12	0.13	1998-06-30
1998-06-10	0.13	1998-06-30
1997-12-15	0.18	1998-01-05
1997-06-12	0.18	1997-06-30
1996-12-12	0.18	1997-01-02
1996-06-13	0.18	1996-06-28
1995-12-14	0.20	1996-01-02
1995-06-15	0.18	1995-06-29
1994-12-12	0.18	1995-01-03
1994-06-14	0.16	1994-06-29
1993-12-13	0.16	1994-01-03
1993-06-15	0.14	1993-06-29
1992-12-14	0.17	1993-01-01
1992-06-16	0.14	1992-06-30
1991-12-09	0.14	1992-01-02
1991-06-04	0.14	1991-06-28
1990-12-10	0.14	1991-01-01
1990-06-05	0.07	1990-07-01
1989-11-27	0.50	1989-12-15
1989-06-06	0.07	1989-07-01
1988-12-12	0.07	1989-01-01
1988-10-24	0.50	1988-11-10
1988-06-07	0.07	1988-07-01
1988-03-30	1.25	1988-04-14
1987-12-15	0.07	1988-01-04
1987-06-08	0.07	1987-07-01
1986-10-07	0.07	1986-10-29
1986-03-24	0.07	1986-04-25
1985-10-22	0.07	1985-11-01
1984-10-02	0.04	1984-10-26
1984-03-26	0.04	1984-04-27
1983-10-04	0.04	1983-10-28
1983-03-28	0.04	1983-04-29
1982-10-05	0.04	1982-10-29
1982-03-30	0.03	1982-04-30
1981-10-06	0.03	1981-10-30
1981-03-31	0.03	1981-05-01
1980-10-07	0.03	1980-10-31
1980-03-30	0.10	1980-05-02
1979-09-30	0.03	1979-11-01
1978-12-10	0.05	1979-01-04
1978-01-08	0.05	1978-01-30
1976-12-27	0.05	1977-01-27
1975-12-25	0.05	1976-01-22

公司名称	Adicet Bio Inc
行业分类	制药
业务描述	Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of 'off-the-shelf' gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Adicet Bio Inc ACET 深 沪

7.03

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Adicet Bio Inc ACET 深沪